These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism. Olmos G, Conde I, Arenas I, Del Peso L, Castellanos C, Landazuri MO, Lucio-Cazana J. Cell Signal; 2007 Oct; 19(10):2098-105. PubMed ID: 17658243 [Abstract] [Full Text] [Related]
4. STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination. Jung JE, Kim HS, Lee CS, Shin YJ, Kim YN, Kang GH, Kim TY, Juhnn YS, Kim SJ, Park JW, Ye SK, Chung MH. Exp Mol Med; 2008 Oct 31; 40(5):479-85. PubMed ID: 18985005 [Abstract] [Full Text] [Related]
5. Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions. Jung YS, Lee SJ, Yoon MH, Ha NC, Park BJ. Cell Cycle; 2012 Dec 01; 11(23):4462-73. PubMed ID: 23159849 [Abstract] [Full Text] [Related]
6. Histone deacetylase inhibitor induced pVHL-independent degradation of HIF-1α and hierarchical quality control of pVHL via chaperone system. Ni J, Ni A. PLoS One; 2021 Dec 01; 16(7):e0248019. PubMed ID: 34329303 [Abstract] [Full Text] [Related]
7. Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes. Lee SH, Che X, Jeong JH, Choi JY, Lee YJ, Lee YH, Bae SC, Lee YM. J Biol Chem; 2012 Apr 27; 287(18):14760-71. PubMed ID: 22351759 [Abstract] [Full Text] [Related]
8. Identification of an alternative mechanism of degradation of the hypoxia-inducible factor-1alpha. André H, Pereira TS. J Biol Chem; 2008 Oct 24; 283(43):29375-84. PubMed ID: 18694926 [Abstract] [Full Text] [Related]
9. Immunoexpression patterns for Hypoxia-inducible Factor-1α and von Hippel-Lindau protein, in relation to Hsp90, of human brain tumors. Assimakopoulou M, Androutsopoulou C, Zolota V, Matsoukas J. Histol Histopathol; 2016 May 24; 31(5):535-46. PubMed ID: 26592496 [Abstract] [Full Text] [Related]
10. VBP1 represses cancer metastasis by enhancing HIF-1α degradation induced by pVHL. Kim JA, Choi DK, Min JS, Kang I, Kim JC, Kim S, Ahn JK. FEBS J; 2018 Jan 24; 285(1):115-126. PubMed ID: 29121446 [Abstract] [Full Text] [Related]
13. Ηypoxia-inducible factor-1α, von Hippel-Lindau protein, and heat shock protein expression in ophthalmic pterygium and normal conjunctiva. Pagoulatos D, Pharmakakis N, Lakoumentas J, Assimakopoulou M. Mol Vis; 2014 Jan 24; 20():441-57. PubMed ID: 24715760 [Abstract] [Full Text] [Related]
14. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition. Chintala S, Najrana T, Toth K, Cao S, Durrani FA, Pili R, Rustum YM. BMC Cancer; 2012 Jul 17; 12():293. PubMed ID: 22804960 [Abstract] [Full Text] [Related]
16. Effects of point mutations in pVHL on the binding of HIF-1α. Domene C, Illingworth CJ. Proteins; 2012 Mar 17; 80(3):733-46. PubMed ID: 22105711 [Abstract] [Full Text] [Related]
17. Low frequency of HIF-1α overexpression in germ cell tumors of the testis. Vranic S, Hes O, Grossmann P, Gatalica Z. Appl Immunohistochem Mol Morphol; 2013 Mar 17; 21(2):165-9. PubMed ID: 22820662 [Abstract] [Full Text] [Related]
18. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation. Zhou J, Schmid T, Frank R, Brüne B. J Biol Chem; 2004 Apr 02; 279(14):13506-13. PubMed ID: 14726529 [Abstract] [Full Text] [Related]